跳至主要内容
临床试验/NCT03579667
NCT03579667已完成不适用

Lipid Profile and Weight After Pregnancy

University of Oslo2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2017年8月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
2
主要终点
Changes in markers of lipid- and glucose metabolism between visits

研究概览

简要总结

A randomized controlled trial aiming to investigate the effects of diet behavior intervention postpartum on body weight and lipid and metabolite profile in overweight and obese women in Oslo, Norway

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women admitted to Adipol, Oslo University Hospital, Norway (outpatient clinic for women with overweight or obesity during pregnancy)

排除标准

  • Twin birth,
  • Non-Norwegian speaking

结局指标

主要结局

Changes in markers of lipid- and glucose metabolism between visits

时间窗: Visit 1 (8 weeks postpartum, visit 2 (6 months postpartum) and visit 3 (15 months postpartum)]

Measured in mmol/l: total cholesterol, low-density lipoprotein, high-density lipoprotein, triglycerides and glucose In percentage: HbA1c In pmol/l: insulin.

Changes in body weight (kg) between visits.

时间窗: Visit 1 (8 weeks postpartum, visit 2 (6 months postpartum) and visit 3 (15 months postpartum)]

Measured in light clothing without shoes. Together with measured height (m) will be used to calculate Body Mass Index.

次要结局

  • Changes in PBMC (peripheral blood mononuclear cell) gene expression levels of markers of inflammation and lipid metabolism between visits.(Visit 1 (8 weeks postpartum, visit 2 (6 months postpartum) and visit 3 (15 months postpartum)])
  • Changes in lipid subclasses (mmol/l), lipoprotein size (nm) and apolipoproteins between visits(Visit 1 (8 weeks postpartum, visit 2 (6 months postpartum) and visit 3 (15 months postpartum)])
  • Changes in circulating inflammation markers such as cytokines, high sensitivity C-Reactive Protein, C-Reactive Protein (CRP) and microCRP between visits.(Visit 1 (8 weeks postpartum, visit 2 (6 months postpartum) and visit 3 (15 months postpartum)])
  • Changes in plasma metabolomics such as lactate, pyruvate, citrate and amino acids between visits.(Visit 1 (8 weeks postpartum, visit 2 (6 months postpartum) and visit 3 (15 months postpartum)])
  • Changes in blood pressure, diastolic and systolic between visits(Visit 1 (8 weeks postpartum, visit 2 (6 months postpartum) and visit 3 (15 months postpartum)])
  • Changes in waist and hip (cm) circumference between visits(Visit 1 (8 weeks postpartum, visit 2 (6 months postpartum) and visit 3 (15 months postpartum)])
  • Changes in body composition (fat free mass in kg and fat mass in kg) between visits.(Visit 1 (8 weeks postpartum, visit 2 (6 months postpartum) and visit 3 (15 months postpartum)])
  • Changes in hemostatic markers such as plasminogen activator inhibitor-1 (PAI-1) antigen and von Willebrand factor (vWF) between visits.(Visit 1 (8 weeks postpartum, visit 2 (6 months postpartum) and visit 3 (15 months postpartum)])
  • Changes in hormones such as prolactin, estradiol, progesterone between visits(Visit 1 (8 weeks postpartum, visit 2 (6 months postpartum) and visit 3 (15 months postpartum)])
  • Changes in markers of micronutrient status such as Hb and vitamin D between visits.(Visit 1 (8 weeks postpartum, visit 2 (6 months postpartum) and visit 3 (15 months postpartum)])
  • Changes in dietary intake and Food Choice by food frequency questionnaire at each of the 3 visits(Visit 1 (8 weeks postpartum, visit 2 (6 months postpartum) and visit 3 (15 months postpartum)])
  • Changes in physical activity between visits.(Visit 1 (8 weeks postpartum, visit 2 (6 months postpartum) and visit 3 (15 months postpartum)])

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hilde Kristin Brekke

Professor

University of Oslo

研究点 (2)

Loading locations...

相似试验

Lipid Profile and Weight After Pregnancy | 临床试验